ACESION PHARMA ApS: Financial statements 2025
CVR: 34083738
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000. The solvency ratio was 96.1%.
- Profit/Loss
- DKK -59,597,000
- Equity
- DKK 276,067,000
- Total Assets
- DKK 287,308,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -59.6 mio. | 276.1 mio. | - |
| 2024 | - | - | -43 mio. | 89.6 mio. | - |
| 2023 | - | - | -42.8 mio. | 130.8 mio. | - |
| 2022 | - | - | -46.8 mio. | 23 mio. | - |
| 2021 | 0 | - | -25.2 mio. | 10.3 mio. | - |
Official annual report
How creditworthy is ACESION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 22, 2025, Novo Holdings A/S is registered as an owner of ACESION PHARMA ApS with an ownership share of 33%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 20%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 15%.
As of December 22, 2025, is registered as an owner of ACESION PHARMA ApS with an ownership share of 5%.
ACESION PHARMA ApS has published its annual report for 2024. The net result was DKK -43,033,000.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.